This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 May;13(5):301-303.

doi: 10.1200/JOP.2017.023333.

Triple-Negative Breast Cancer: Current Practice and Future Directions

Ricardo L B Costa¹, William J Gradishar¹

Affiliations

PMID: 28489982
DOI: 10.1200/JOP.2017.023333

Comment

Triple-Negative Breast Cancer: Current Practice and Future Directions

Ricardo L B Costa et al. J Oncol Pract. 2017 May.

. 2017 May;13(5):301-303.

doi: 10.1200/JOP.2017.023333.

Authors

Ricardo L B Costa¹, William J Gradishar¹

Affiliation

¹ Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

PMID: 28489982
DOI: 10.1200/JOP.2017.023333

No abstract available

PubMed Disclaimer

Comment on

Practical Approach to Triple-Negative Breast Cancer.
Gadi VK, Davidson NE. Gadi VK, et al. J Oncol Pract. 2017 May;13(5):293-300. doi: 10.1200/JOP.2017.022632. J Oncol Pract. 2017. PMID: 28489980 Review.

Similar articles

Outstanding Questions in the Clinical Management of Triple-Negative Breast Cancer.
Gruber JJ, Telli ML. Gruber JJ, et al. J Oncol Pract. 2017 May;13(5):305-307. doi: 10.1200/JOP.2017.023341. J Oncol Pract. 2017. PMID: 28489983 No abstract available.
Triple-negative breast cancer in the elderly.
Shagisultanova E, Mayordomo J, Elias AD. Shagisultanova E, et al. Breast J. 2017 Nov;23(6):627-629. doi: 10.1111/tbj.12814. Breast J. 2017. PMID: 29112794 No abstract available.
Association between aspirin use triple negative breast cancer: More benefit is expected.
Altundag K. Altundag K. Cancer Epidemiol. 2017 Jun;48:157. doi: 10.1016/j.canep.2017.02.007. Epub 2017 Mar 6. Cancer Epidemiol. 2017. PMID: 28268162 No abstract available.
Triple-negative breast cancer: role of the androgen receptor.
Gucalp A, Traina TA. Gucalp A, et al. Cancer J. 2010 Jan-Feb;16(1):62-5. doi: 10.1097/PPO.0b013e3181ce4ae1. Cancer J. 2010. PMID: 20164692 Review.
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions.
Santa-Maria CA, Camp M, Cimino-Mathews A, Harvey S, Wright J, Stearns V. Santa-Maria CA, et al. Oncology (Williston Park). 2015 Nov;29(11):828-38. Oncology (Williston Park). 2015. PMID: 26573062 Review.

See all similar articles

Cited by

Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells.
Malla S, Nyinawabera A, Neupane R, Pathak R, Lee D, Abou-Dahech M, Kumari S, Sinha S, Tang Y, Ray A, Ashby CR Jr, Yang MQ, Babu RJ, Tiwari AK. Malla S, et al. Cancers (Basel). 2024 Jul 23;16(15):2621. doi: 10.3390/cancers16152621. Cancers (Basel). 2024. PMID: 39123351 Free PMC article.
Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09.
Nirgude S, Desai S, Choudhary B. Nirgude S, et al. BMC Genomics. 2022 Dec 6;23(1):807. doi: 10.1186/s12864-022-09041-2. BMC Genomics. 2022. PMID: 36474139 Free PMC article.
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.
Bagegni NA, Davis AA, Clifton KK, Ademuyiwa FO. Bagegni NA, et al. Breast Cancer (Dove Med Press). 2022 Apr 29;14:113-123. doi: 10.2147/BCTT.S293597. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 35515356 Free PMC article. Review.
Identification of novel genes for triple-negative breast cancer with semiparametric gene-based analysis.
Liu X, Tian G, Liu Z. Liu X, et al. J Appl Stat. 2021 Sep 11;50(3):691-702. doi: 10.1080/02664763.2021.1973387. eCollection 2023. J Appl Stat. 2021. PMID: 36819073 Free PMC article.
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer.
Fernandez AI, Geng X, Chaldekas K, Harris B, Duttargi A, Berry VL, Berry DL, Mahajan A, Cavalli LR, Győrffy B, Tan M, Riggins RB. Fernandez AI, et al. Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007/s10549-019-05485-5. Epub 2019 Nov 19. Breast Cancer Res Treat. 2020. PMID: 31741180 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations